GROWTH HORMONE

The GROWTH HORMONE test evaluates hormones produced by the pituitary gland that regulate growth, metabolism and tissue repair. Because pituitary GH is secreted in pulses, a single GH measurement can be unreliable; home collection services commonly measure Insulin‑like Growth Factor 1 (IGF‑1) and related binding proteins to provide a stable, lab‑certified indication of overall GH activity. Reliable measurement supports diagnosis and monitoring of growth disorders, GH deficiency, and excess GH conditions such as acromegaly.

This home testing option combines convenient sample collection across Dubai and the UAE with accredited laboratory analysis and fast result delivery to help inform endocrine and fertility care decisions. It is suitable for pediatric growth assessments, adults with suspected pituitary dysfunction, patients on GH replacement or suppression therapy, and couples requiring endocrine evaluation as part of fertility workups. Results should be interpreted by a qualified endocrinologist or treating physician, who may recommend further dynamic testing in a clinical setting when needed.

• Growth Hormone (GH)
• Insulin-like Growth Factor 1 (IGF-1)
• IGF Binding Protein-3 (IGFBP-3)

• Children with poor linear growth or short stature
• Delayed puberty or unexplained growth failure
• Adults with symptoms of GH deficiency (fatigue, loss of muscle mass)
• Signs suggestive of acromegaly (enlarged hands/feet, coarse facial changes)
• Monitoring response to GH replacement or suppression therapy

• Home venous sample collection by trained phlebotomists across Dubai and the UAE
• Accredited laboratory analysis with fast turnaround
• Stable biomarkers (IGF‑1/IGFBP‑3) reduce variability from pulsatile GH secretion
• Supports diagnosis, treatment planning and monitoring for endocrine and fertility care
• Electronic delivery of results and option for clinician review

• At‑home venous blood sample collection by a trained professional
• Morning sample recommended (preferably before 10:00 AM) to reduce biological variability
• Avoid strenuous exercise and excessive alcohol 24 hours before sampling
• Inform the team about medications (steroids, estrogens, insulin, current GH therapy) and pregnancy; note dynamic stimulation/suppression tests require a clinic visit